Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil (2018)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - EERP ; COLOGNA, ADAUTO JOSE - FMRP ; MARTINS, ANTONIO CARLOS PEREIRA - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1038/tpj.2017.2
- Subjects: POLIMORFISMO; DISFUNÇÃO ERÉTIL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 18, n. 2, p. 238-244, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LACCHINI, Riccardo et al. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. The Pharmacogenomics Journal, v. 18, n. 2, p. 238-244, 2018Tradução . . Disponível em: https://doi.org/10.1038/tpj.2017.2. Acesso em: 30 dez. 2025. -
APA
Lacchini, R., Muniz, J. J., Nobre, Y. T. D. A., Cologna, A. J., Martins, A. C. P., & Tanus-Santos, J. E. (2018). Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. The Pharmacogenomics Journal, 18( 2), 238-244. doi:10.1038/tpj.2017.2 -
NLM
Lacchini R, Muniz JJ, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil [Internet]. The Pharmacogenomics Journal. 2018 ; 18( 2): 238-244.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1038/tpj.2017.2 -
Vancouver
Lacchini R, Muniz JJ, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil [Internet]. The Pharmacogenomics Journal. 2018 ; 18( 2): 238-244.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1038/tpj.2017.2 - Relationship between Arginase 1 and Arginase 2 levels and genetic polymorphisms with erectile dysfunction
- VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction
- nNOS polymorphisms are associated with responsiveness to sildenafil in clinical and postoperative erectile dysfunction
- Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction
- Plasma arginase activity may affect the responses to sildenafil in patients with erectile dysfunction
- Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction
- Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension
- Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril
- Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
- Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
Informações sobre o DOI: 10.1038/tpj.2017.2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
